1. Home
  2. CCO vs PVLA Comparison

CCO vs PVLA Comparison

Compare CCO & PVLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Clear Channel Outdoor Holdings Inc.

CCO

Clear Channel Outdoor Holdings Inc.

N/A

Current Price

$2.38

Market Cap

1.2B

ML Signal

N/A

Logo Palvella Therapeutics Inc.

PVLA

Palvella Therapeutics Inc.

N/A

Current Price

$134.20

Market Cap

1.2B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CCO
PVLA
Founded
1995
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Advertising
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.2B
IPO Year
2005
N/A

Fundamental Metrics

Financial Performance
Metric
CCO
PVLA
Price
$2.38
$134.20
Analyst Decision
Hold
Strong Buy
Analyst Count
6
17
Target Price
$2.21
$154.59
AVG Volume (30 Days)
10.4M
332.9K
Earning Date
05-27-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
110.81
N/A
EPS
0.04
N/A
Revenue
$1,604,140,000.00
N/A
Revenue This Year
$5.23
N/A
Revenue Next Year
$3.20
N/A
P/E Ratio
$59.38
N/A
Revenue Growth
6.57
N/A
52 Week Low
$0.81
$18.23
52 Week High
$2.43
$151.18

Technical Indicators

Market Signals
Indicator
CCO
PVLA
Relative Strength Index (RSI) 58.75 67.21
Support Level $2.37 $85.53
Resistance Level N/A $151.18
Average True Range (ATR) 0.03 9.13
MACD -0.01 3.01
Stochastic Oscillator 21.43 75.28

Price Performance

Historical Comparison
CCO
PVLA

About CCO Clear Channel Outdoor Holdings Inc.

Clear Channel Outdoor Holdings Inc is a provider of out-of-home advertising solutions. The company offers advertisers an opportunity to reach mass audiences across various high-traffic public spaces, by using its diverse portfolio of assets including roadside billboards, street furniture, and airport displays. Its reportable segments are; America (U.S. operations excluding airports), Airports (U.S. and Caribbean airport operations), and Other. A majority of its revenue is generated from the America segment which generates revenue from the sale of advertising on printed and digital out-of-home advertising displays such as bulletins, posters, street furniture, and others. Geographically, the company generates maximum revenue from the United States followed by Singapore.

About PVLA Palvella Therapeutics Inc.

Palvella Therapeutics Inc is a late clinical-stage biopharmaceutical company committed to serving individuals suffering from serious, rare genetic skin diseases without approved therapies. The Company's lead product candidate, QTORIN 3.9 percent rapamycin anhydrous gel (QTORIN rapamycin), is based on the Company's patented QTORIN platform. QTORIN rapamycin is in clinical development for two rare genetic skin disorders.

Share on Social Networks: